Pharma Tech Outlook | Advancing Pharma Technology

Olga Minkov, Medical Operations, SSI Strategy | Pharma Tech Outlook

Beyond The Buzz: Making AI Work for Pharmacovigilance Under Regulatory Scrutiny

By Olga Minkov, Medical Operations, SSI Strategy

Viatris Inc. [NASDAQ: VTRS]
Real-World Data Discoverability
Kelly H. Zou, Ph.D., PStat®, FASA, Head, Global Medical Analytics and Real World Evidence Clinical Development and Medical Affairs, Viatris Inc.
Agios Pharmaceuticals [NASDAQ: AGIO]
An Era of Digital Initiatives in Medical Affairs
Eva Gallagher, Vice President, Head of Global Medical Affairs, Agios Pharmaceuticals
Mallinckrodt Pharmaceuticals [NYSE: MNK]
Quality Assurance Transformations and Innovations in Pharma Tech
Tony Johnson, Senior Director, Global Clinical Quality Assurance, Mallinckrodt Pharmaceuticals
Sanofi CHC [EPA: SAN]
A Holistic Approach to Integrated Marketing and Responsible Leadership
Cynthia Lopez, Global Marketing Excellence Director, Sanofi CHC
Pfizer [NYSE:PFE]
Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical Ingredient
Nick Thomson, Senior Director, Chemical Research and Development, Pfizer
BeiGene [SHA: 688235]
Challenges to Clinical System in China
Cheryl Chen, Director of Clinical Operations, BeiGene
Sanofi [EPA: SAN]
Chasing the Miracles of Science to Improve People's Lives
Paul Rowe, MD, ATSF, Senior Vice President, Head of Medical, Specialty Care, Immunology, Sanofi
Lonza [SWX: LONN]
Potential of Cell and Gene Therapy
Alexis Bossie, Head of Media R&D, Lonza
Novartis [SWX: NOVN]
Measurement of a Compliance Programme
Rauno Hoffmann, Global Head of Corporate Compliance Management System
Novo Nordisk [CPH: NOVO-B]
Strengthening Patient Centricity in Drug Development: The New Evolution in Pharma
Liselotte Hyveled, Board member

Drug Discovery and Development

Carlos Pedraza, PhD. Director of CNS Biology, Alkermes. | Pharma Tech Outlook

Innovation vs Validation in Early Drug Discovery

Carlos Pedraza, PhD. Director of CNS Biology, Alkermes.

Dr. George Y. Li, CombiPhos Catalysts | Pharma Tech Outlook

CombiPhos Catalysts: Unlocking the Full Potential of Deuterium Chemistry

Dr. George Y. Li, Founder and President

Rafal Lunio, Director of Research & Development, Qualified Person (QP), Polfa Tarchomin S.A | Pharma Tech Outlook

R&D in the Age of Digital Transformation and Artificial Intelligence: How Pharma R&D Is Evolving

Rafal Lunio, Director of Research & Development, Qualified Person (QP), Polfa Tarchomin S.A

eClinical Trial Management

Dawn Niccum, Executive Vice President, Quality Assurance, inSeption Group | Pharma Tech Outlook

Evolving Good Clinical Practice and Modernizing the trial Master file

Dawn Niccum, Executive Vice President, Quality Assurance, inSeption Group

Larry E. Elvebak, LabIntegrity | Pharma Tech Outlook

LabIntegrity: Tackling the Burden of Bioanalysis Reporting

Larry E. Elvebak, President

Haichen Yang, MD, MA, MBA, Vice President, Clinical Research, Amicus Therapeutics Inc [NASDAQ: FOLD] | Pharma Tech Outlook

Historical Control in Gene Therapy Clinical Development

Haichen Yang, MD, MA, MBA, Vice President, Clinical Research, Amicus Therapeutics Inc [NASDAQ: FOLD]

Pharma Manufacturing

Dottie Barr, Senior Vice President Manufacturing & Technical Operations, Lantheus [NASDAQ: LNTH] | Pharma Tech Outlook

Innovation and Excellence in Radiopharmaceutical Operations

Dottie BarrSenior Vice President Manufacturing & Technical OperationsLantheus [NASDAQ: LNTH]

Stephen Lam, Bora Biologics | Pharma Tech Outlook

Bora Biologics: The Full-Spectrum Biologics Builders

Stephen Lam, CEO

Erik Lemay, Head of Global External Manufacturing, Servier | Pharma Tech Outlook

Complexities in the Development Process for Pharmaceutical Manufacturing

Erik LemayHead of Global External ManufacturingServier

Pharmacy Management

Jim Kremidas, Executive director, Association of Clinical Research Professionals | Pharma Tech Outlook

Present-Day Clinical Trial Landscape

Jim Kremidas, Executive director, Association of Clinical Research Professionals

Davin Deb, True Marker Pharmaceuticals | Pharma Tech Outlook

True Marker Pharmaceuticals: The Quiet Work Behind Every Prescription

Davin Deb, CEO

Lawrence Fernandes, Director, Asia Pacific Human Health IT, MSD | Pharma Tech Outlook

The Role of IT Leaders, Reimagined for Pharma in Asia

Lawrence Fernandes, Director, Asia Pacific Human Health IT, MSD

Safwan Kezbor, M.D., Global Medical Lead, (Senior Medical Director), Clinical Development, Shionogi Inc | Pharma Tech Outlook

A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and Innovations

Safwan Kezbor, M.D., Global Medical Lead, (Senior Medical Director), Clinical Development, Shionogi Inc

Pharma Safety & Compliance

Rishi Kakar, Chief Scientific Officer and Medical Director, Segal Trials | Pharma Tech Outlook

Advancing Clinical Research Through Scientific Rigor and Innovation

Rishi Kakar, Chief Scientific Officer and Medical Director, Segal Trials

Cori L. Rizman, Vice President of DEA Compliance, Ascent Pharmaceuticals, Inc | Pharma Tech Outlook

Inside DEA Compliance: Risk, Pressure, and Leadership

Cori L. Rizman, Vice President of DEA Compliance, Ascent Pharmaceuticals, Inc

Jennifer Vavala, Executive Director, Quality and Compliance, PCI Pharma Services | Pharma Tech Outlook

Navigating Regulatory Complexity in Pharma Operations

Jennifer Vavala, Executive Director, Quality and Compliance, PCI Pharma Services

In The News

Laboratory Automation: A Sustainable Approach!

Casting Our NETs for ARDS

Infection Detection and Management: A Huge Burden to Health Systems

Navigating Global R&D and Pharmacokinetics In Oncology